References
- Banerjee, R., Liu, J., Beatty, W., Pelosof, L., Klemba, M., & Goldberg, D. E. (2002). Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proceedings of the National Academy of Sciences, 99(2), 990–995. https://doi.org/https://doi.org/10.1073/pnas.022630099
- Berendsen, H. J., Postma, J. v., van Gunsteren, W. F., DiNola, A., & Haak, J. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/https://doi.org/10.1063/1.448118
- Bhattacharjee, A. K., Hartell, M. G., Nichols, D. A., Hicks, R. P., Stanton, B., Van Hamont, J. E., & Milhous, W. K. (2004). Structure-activity relationship study of antimalarial indolo [2, 1-b] quinazoline-6, 12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates. European Journal of Medicinal Chemistry, 39(1), 59–67. https://doi.org/https://doi.org/10.1016/j.ejmech.2003.10.004
- Bietz, S., Urbaczek, S., Schulz, B., & Rarey, M. (2014). Protoss: A holistic approach to predict tautomers and protonation states in protein-ligand complexes. Journal of Cheminformatics, 6(1), 12. p https://doi.org/https://doi.org/10.1186/1758-2946-6-12
- Bobrovs, R., Jaudzems, K., & Jirgensons, A. (2019). Exploiting structural dynamics to design open-flap inhibitors of malarial aspartic proteases. Journal of Medicinal Chemistry, 62(20), 8931–8950. https://doi.org/https://doi.org/10.1021/acs.jmedchem.9b00184
- Boddey, J. A. (2017). Plasmepsins on the antimalarial hit list. Science (New York, N.Y.).), 358(6362), 445–446. https://doi.org/https://doi.org/10.1126/science.aaq0002
- Böhm, H.-J. (1994). The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. Journal of Computer-Aided Molecular Design, 8(3), 243–256.
- Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., & Sacerdoti, F. D. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. SC 2006 Conference, Proceedings of the ACM/IEEE.
- Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983). CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. Journal of Computational Chemistry, 4(2), 187–217. https://doi.org/https://doi.org/10.1002/jcc.540040211
- Cheuka, P. M., Dziwornu, G., Okombo, J., & Chibale, K. (2020). Plasmepsin inhibitors in antimalarial drug discovery: Medicinal chemistry and target validation (2000–Present). Journal of Medicinal Chemistry, 63(9), 4445–4467.
- Coombs, G. H., Goldberg, D. E., Klemba, M., Berry, C., Kay, J., & Mottram, J. C. (2001). Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends in Parasitology, 17(11), 532–537. https://doi.org/https://doi.org/10.1016/S1471-4922(01)02037-2
- D. E. Shaw Research. (2016). Maestro-desmond interoperability tools, Desmond Molecular Dynamics System, New York, NY, Schrödinger, New York, NY, 2016
- Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅ log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/https://doi.org/10.1063/1.464397
- Degliesposti, G., Kasam, V., Da Costa, A., Kang, H.-K., Kim, N., Kim, D.-W., Breton, V., Kim, D., & Rastelli, G. (2009). Design and discovery of plasmepsin II inhibitors using an automated workflow on large-scale grids. ChemMedChem, 4(7), 1164–1173. https://doi.org/https://doi.org/10.1002/cmdc.200900111
- Discovery Studio version 4.0. (2012). Accelrys Software, Inc. www.accelrys.com/products/collaborativescience/biovia-discovery-studio/
- Eder, J., Hommel, U., Cumin, F., Martoglio, B., & Gerhartz, B. (2007). Aspartic proteases in drug discovery. Current Pharmaceutical Design, 13(3), 271–285. https://doi.org/https://doi.org/10.2174/138161207779313560
- Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., & Overington, J. P. (2012). ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Research, 40(Database issue), D1100–D1107. https://doi.org/https://doi.org/10.1093/nar/gkr777
- Gregson, A., & Plowe, C. V. (2005). Mechanisms of resistance of malaria parasites to antifolates. Pharmacological Reviews, 57(1), 117–145. https://doi.org/https://doi.org/10.1124/pr.57.1.4
- Gu, J., Gui, Y., Chen, L., Yuan, G., Lu, H.-Z., & Xu, X. (2013). Use of natural products as chemical library for drug discovery and network pharmacology. PloS One, 8(4), e62839. p https://doi.org/https://doi.org/10.1371/journal.pone.0062839
- Güner, O. F. (2000). Pharmacophore perception, development, and use in drug design: Internat'l University Line.
- Head, J. D., & Zerner, M. C. (1985). A Broyden—Fletcher—Goldfarb—Shanno optimization procedure for molecular geometries. Chemical Physics Letters, 122(3), 264–270. https://doi.org/https://doi.org/10.1016/0009-2614(85)80574-1
- Hill, J., Tyas, L., Phylip, L. H., Kay, J., Dunn, B. M., & Berry, C. (1994). High level expression and characterisation of Plasmepsin II, an aspartic proteinase from Plasmodium falciparum. FEBS Letters, 352(2), 155–158. https://doi.org/https://doi.org/10.1016/0014-5793(94)00940-6
- Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935. https://doi.org/https://doi.org/10.1063/1.445869
- Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996). Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society, 118(45), 11225–11236. https://doi.org/https://doi.org/10.1021/ja9621760
- Klemba, M., & Goldberg, D. E. (2005). Characterization of plasmepsin V, a membrane-bound aspartic protease homolog in the endoplasmic reticulum of Plasmodium falciparum. Molecular and Biochemical Parasitology, 143(2), 183–191. https://doi.org/https://doi.org/10.1016/j.molbiopara.2005.05.015
- Kontoyianni, M., McClellan, L. M., & Sokol, G. S. (2004). Evaluation of docking performance: Comparative data on docking algorithms. Journal of Medicinal Chemistry, 47(3), 558–565. https://doi.org/https://doi.org/10.1021/jm0302997
- Kramer, B., Rarey, M., & Lengauer, T. (1997). CASP2 experiences with docking flexible ligands using FlexX. Proteins: Structure, Function, and Genetics, 29(S1), 221–225. https://doi.org/https://doi.org/10.1002/(SICI)1097-0134(1997)1+<221::AID-PROT30>3.0.CO;2-O
- Lagunin, A., Filimonov, D., & Poroikov, V. (2010). Multi-targeted natural products evaluation based on biological activity prediction with PASS. Current Pharmaceutical Design, 16(15), 1703–1717. https://doi.org/https://doi.org/10.2174/138161210791164063
- Lambrakos, S., Boris, J., Oran, E., Chandrasekhar, I., & Nagumo, M. (1989). A modified shake algorithm for maintaining rigid bonds in molecular dynamics simulations of large molecules. Journal of Computational Physics, 85(2), 473–486. https://doi.org/https://doi.org/10.1016/0021-9991(89)90160-5
- LeadIT version 2.1.8. (2017). BioSolveIT GmbH. Sankt Augustin. www.biosolveit.de/LeadIT
- Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1-3), 3–25. https://doi.org/https://doi.org/10.1016/S0169-409X(96)00423-1
- Liu, J., Gluzman, I. Y., Drew, M. E., & Goldberg, D. E. (2005). The role of Plasmodium falciparum food vacuole plasmepsins. The Journal of Biological Chemistry, 280(2), 1432–1437. https://doi.org/https://doi.org/10.1074/jbc.M409740200
- Liu, J., Istvan, E. S., & Goldberg, D. E. (2006). Hemoglobin-degrading plasmepsin II is active as a monomer. The Journal of Biological Chemistry, 281(50), 38682–38688. https://doi.org/https://doi.org/10.1074/jbc.M608535200
- Liu, J., Zhu, Y., He, Y., Zhu, H., Gao, Y., Li, Z., & Wen, H. (2019). Combined pharmacophore modeling, 3D-QSAR and docking studies to identify novel HDAC inhibitors using drug repurposing. Journal of Biomolecular Structure and Dynamics, 38(2), 533–47.
- Lone, M. Y., Kumar, S. P., Athar, M., & Jha, P. C. (2018). Exploration of Mycobacterium tuberculosis structural proteome: An in-silico approach. Journal of Theoretical Biology, 439, 14–23. https://doi.org/https://doi.org/10.1016/j.jtbi.2017.11.021
- Lone, M. Y., Manhas, A., Athar, M., & Jha, P. C. (2018). Identification of InhA inhibitors: A combination of virtual screening, molecular dynamics simulations and quantum chemical studies. Journal of Biomolecular Structure & Dynamics, 36(11), 2951–2965. https://doi.org/https://doi.org/10.1080/07391102.2017.1372313
- Manhas, A., Dubey, S., & Jha, P. C. (2019). A profound computational study to prioritize the natural compound inhibitors against the P. falciparum orotidine-5-monophosphate decarboxylase enzyme. Journal of Biomolecular Structure and Dynamics, 38(9), 2704–2716.
- Manhas, A., Lone, M. Y., & Jha, P. C. (2017). Multicomplex-based pharmacophore modeling coupled with molecular dynamics simulations: An efficient strategy for the identification of novel inhibitors of PfDHODH. Journal of Molecular Graphics & Modelling, 75, 413–423. https://doi.org/https://doi.org/10.1016/j.jmgm.2017.04.025
- Manhas, A., Lone, M. Y., & Jha, P. C. (2019a). In search of the representative pharmacophore hypotheses of the enzymatic proteome of Plasmodium falciparum: A multicomplex-based approach. Molecular Diversity, 23(2), 453–470. https://doi.org/https://doi.org/10.1007/s11030-018-9885-5
- Manhas, A., Lone, M. Y., & Jha, P. C. (2019b). Multicomplex-based pharmacophore modeling in conjunction with multi-target docking and molecular dynamics simulations for the identification of PfDHFR inhibitors. Journal of Biomolecular Structure & Dynamics, 37(16), 4181–4199. https://doi.org/https://doi.org/10.1080/07391102.2018.1540362
- Manhas, A., Patel, D., Lone, M. Y., & Jha, P. C. (2019). Identification of natural compound inhibitors against PfDXR: A hybrid structure‐based molecular modeling approach and molecular dynamics simulation studies. Journal of Cellular Biochemistry, 120(9), 14531–14543. https://doi.org/https://doi.org/10.1002/jcb.28714
- Martyna, G. J., Tobias, D. J., & Klein, M. L. (1994). Constant pressure molecular dynamics algorithms. The Journal of Chemical Physics, 101(5), 4177–4189. https://doi.org/https://doi.org/10.1063/1.467468
- Mastan, B. S., Kumari, A., Gupta, D., Mishra, S., & Kumar, K. A. (2014). Gene disruption reveals a dispensable role for plasmepsin VII in the Plasmodium berghei life cycle. Molecular and Biochemical Parasitology, 195(1), 10–13. https://doi.org/https://doi.org/10.1016/j.molbiopara.2014.05.004
- Mastan, B. S., Narwal, S. K., Dey, S., Kumar, K. A., & Mishra, S. (2017). Plasmodium berghei plasmepsin VIII is essential for sporozoite gliding motility. International Journal for Parasitology, 47(5), 239–245. https://doi.org/https://doi.org/10.1016/j.ijpara.2016.11.009
- McKay, P. B., Peters, M. B., Carta, G., Flood, C. T., Dempsey, E., Bell, A., & Fayne, D. (2011). Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design. Bioorganic & Medicinal Chemistry Letters, 21(11), 3335–3341.
- Moura, P. A., Dame, J. B., & Fidock, D. A. (2009). Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors. Antimicrobial Agents and Chemotherapy, 53(12), 4968–4978. https://doi.org/https://doi.org/10.1128/AAC.00882-09
- Naman, C. B., Leber, C. A., & Gerwick, W. H. (2017). Modern natural products drug discovery and its relevance to biodiversity conservation. Microbial Resources. (pp. 103–120).
- Nasamu, A. S., Glushakova, S., Russo, I., Vaupel, B., Oksman, A., Kim, A. S., Fremont, D. H., Tolia, N., Beck, J. R., Meyers, M. J., Niles, J. C., Zimmerberg, J., & Goldberg, D. E. (2017). Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion. Science (New York, N.Y.).), 358(6362), 518–522. https://doi.org/https://doi.org/10.1126/science.aan1478
- Nosé, S. (1984). A unified formulation of the constant temperature molecular dynamics methods. The Journal of Chemical Physics, 81(1), 511–519. https://doi.org/https://doi.org/10.1063/1.447334
- Olanlokun, J. O., Olotu, A. F., David, O. M., Idowu, T. O., Soliman, E. M., & Olorunsogo, O. O. (2019). A novel compound purified from Alstonia boonei inhibits Plasmodium falciparum lactate dehydrogenase and plasmepsin II. Journal of Biomolecular Structure & Dynamics, 37(8), 2193–2200. https://doi.org/https://doi.org/10.1080/07391102.2018.1483840
- Omotuyi, I., & Hamada, T. (2015). Dynamical footprint of falcipain-2 catalytic triad in hemoglobin-β-bound state. Journal of Biomolecular Structure & Dynamics, 33(5), 1027–1036. https://doi.org/https://doi.org/10.1080/07391102.2014.924878
- Pino, P., Caldelari, R., Mukherjee, B., Vahokoski, J., Klages, N., Maco, B., Collins, C. R., Blackman, M. J., Kursula, I., Heussler, V., Brochet, M., & Soldati-Favre, D. (2017). A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress. Science (New York, N.Y.).), 358(6362), 522–528. https://doi.org/https://doi.org/10.1126/science.aaf8675
- Qidwai, T., K., Yadav, D., Khan, F., Dhawan, S., S., & Bhakuni, R. (2012). QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum. Current Pharmaceutical Design, 18(37), 6133–6154. https://doi.org/https://doi.org/10.2174/138161212803582397
- Rarey, M., Kramer, B., Lengauer, T., & Klebe, G. (1996). A fast flexible docking method using an incremental construction algorithm. Journal of Molecular Biology, 261(3), 470–489. https://doi.org/https://doi.org/10.1006/jmbi.1996.0477
- Rasina, D., Otikovs, M., Leitans, J., Recacha, R., Borysov, O. V., Kanepe-Lapsa, I., Domraceva, I., Pantelejevs, T., Tars, K., Blackman, M. J., Jaudzems, K., & Jirgensons, A. (2016). Fragment-based discovery of 2-aminoquinazolin-4(3H)-ones as novel class nonpeptidomimetic inhibitors of the plasmepsins I, II, and IV . Journal of Medicinal Chemistry, 59(1), 374–387. https://doi.org/https://doi.org/10.1021/acs.jmedchem.5b01558
- Saxena, S., Durgam, L., & Guruprasad, L. (2019). Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH). Journal of Biomolecular Structure & Dynamics, 37(7), 1783–1799. https://doi.org/https://doi.org/10.1080/07391102.2018.1471417
- Shrivastava, A., Srivastava, S., Malik, R., Alam, M. M., Shaqiquzamman, M., & Akhter, M. (2020). Identification of novel small molecule non-peptidomimetic inhibitor for prolyl oligopeptidase through in silico and in vitro approaches. Journal of Biomolecular Structure & Dynamics, 38(5), 1292–1305. https://doi.org/https://doi.org/10.1080/07391102.2019.1602078
- Silva, A. M., Lee, A. Y., Gulnik, S. V., Maier, P., Collins, J., Bhat, T. N., Collins, P. J., Cachau, R. E., Luker, K. E., Gluzman, I. Y., Francis, S. E., Oksman, A., Goldberg, D. E., & Erickson, J. W. (1996). Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America, 93(19), 10034–10039. https://doi.org/https://doi.org/10.1073/pnas.93.19.10034
- Stierand, K., & Rarey, M. (2010). Drawing the PDB: Protein − ligand complexes in two dimensions. ACS Medicinal Chemistry Letters, 1(9), 540–545. https://doi.org/https://doi.org/10.1021/ml100164p
- SYBYL. (1994). TRIPOS Associates Inc. http://www.tripos.com/
- Tan, D. S. (2004). Current progress in natural product-like libraries for discovery screening. Combinatorial Chemistry & High Throughput Screening, 7(7), 631–643. https://doi.org/https://doi.org/10.2174/1386207043328418
- Thillainayagam, M., Malathi, K., Anbarasu, A., Singh, H., Bahadur, R., & Ramaiah, S. (2019). Insights on inhibition of Plasmodium falciparum plasmepsin I by novel epoxyazadiradione derivatives–molecular docking and comparative molecular field analysis. Journal of Biomolecular Structure & Dynamics, 37(12), 3168–3182. https://doi.org/https://doi.org/10.1080/07391102.2018.1510342
- Thillainayagam, M., Ramaiah, S., & Anbarasu, A. (2020). Molecular docking and dynamics studies on novel benzene sulfonamide substituted pyrazole-pyrazoline analogues as potent inhibitors of Plasmodium falciparum Histo aspartic protease. Journal of Biomolecular Structure & Dynamics, 38(11), 3235–3211. https://doi.org/https://doi.org/10.1080/07391102.2019.1654923
- Tuckerman, M., Berne, B. J., & Martyna, G. J. (1992). Reversible multiple time scale molecular dynamics. The Journal of Chemical Physics, 97(3), 1990–2001. https://doi.org/https://doi.org/10.1063/1.463137
- Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/https://doi.org/10.1021/jm020017n
- WHO. (2017). World malaria report 2017. In: WHO Global Malaria Programme. World Health Organization.
- WHO. (2020). World malaria report 2019. World Health organization. 2019, 1–210 p.
- Yamashita, F., & Hashida, M. (2004). In silico approaches for predicting ADME properties of drugs. Drug Metabolism and Pharmacokinetics, 19(5), 327–338. https://doi.org/https://doi.org/10.2133/dmpk.19.327